metabolic
Survodutide
Glucagon/GLP-1 dual agonist
0 vendors tracked0 live pricesLast crawl: warming up
About
A dual glucagon/GLP-1 receptor agonist in clinical trials for obesity and MASH. Research-compound version sold as the free acid.
Also known as: BI-456906, PGL-GC1, Survodutide (PGL-GC1)
Reconstitution calculator
!
For research purposes only. Not for human consumption. Always verify calculations independently.
Cost-per-dose recalculates as you adjust the calculator above.
Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.
Keep exploring
More on Survodutide & related research
Related peptides
- Retatrutide— Triple GCG/GIP/GLP-1 agonist
- Mazdutide— GLP-1/glucagon dual agonist
- Semaglutide— GLP-1 agonist for metabolic research
- Tirzepatide— Dual GLP-1/GIP agonist
- Orforglipron— Oral small-molecule GLP-1 agonist
Compare head-to-head